Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
5-(Trifluoromethyl)-1,3,4-oxadiazol-2-amine → 9H-Xanthene-9carboxylic acid (5-trifluoromethyl-[1,3,4]oxadiazol-2-yl)-amide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 5-(Trifluoromethyl)-1,3,4-oxadiazol-2-amine | HCID 522630 | — |
| 반응물 | (3,5-dimethylpyrazol-1-yl)-(9H-xanthen-9-yl)methanone | HCID 4521579 | — |
| 생성물 | 9H-Xanthene-9carboxylic acid (5-trifluoromethyl-[1,3,4]oxadiazol-2-yl)-amide | HCID 53955883 | — |
반응 단계
The title compound, white solid, m.p. 220-223° C.(decomp.), and MS: m/e=362.2 (M+H+) was prepared in accordance with the general method of example 48a from (3,5-dimethylpyrazol-1-yl)-(9H-xanthen-9-yl)-methanone and 5-trifluoromethyl-[1,3,4]oxadiazol-2-ylamine [U.S. Pat. No. 2,883,391].
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US06803381B1 |
| 출처 데이터셋 | uspto-grants-2004_10 |
| ORD ID | ord-96c3b3a4103c47e79f199a5632fc2952 |
| 출처 메모 | uspto-grants-2004_10 |